Member Info for Citizenlane

stt1 why not concentrate on your daily hyping of TLY, which looks a decent shout as a company (albeit in a competitive and politically sensitive field)? Very tedious reading you trolling so unimaginatively on here.

JB I think the word you are after is RENEGE

here's a thing, stt1, it's clearly both a unique Covid and, more broadly, a unique infectious disease share; the one highlights the other and there is little other news in town for the forseeable future imvho

I know this isn’t only a covid stock but it’s hard to imagine that the arrival of this variant and a whole Greek alphabet to follow isn’t going to put a premium on vaccine and antiviral testing in the very near future. We are clearly not at the beginning of the end of covid and maybe not even at the end of the beginning -and what it shows is that health systems around the world can’t cope with much extra stress from infectious disease. Prevention will be key to saving the global economy. OO has a key role to play imho, large CROs will not sit on their hands for much longer I’d say before testing a bid prob including DiM…

“And what did you do today Daddy Jim?”
“Well, son, I spent another day obsessively talking down a share I have scant interest in on an anonymised message board…”

coming, by the looks of those 23p trades, OO has always been a relatively leaky ship, someone has got wind of something imminent imho

JB, ever think you might have an unhealthy fixation? There are plenty more things in the world to get this angry about before Cathal Friel’s enthusiasm for his company. Have a look at a newspaper.

SP has drifted down on negligible volume, just a few PIs cashing in and looking elsewhere for their christmas beer money, plenty of news to come, even if prob early in new year. Order book remains full, DiM still promises much, and the covid project will start to bear fruit imho, the more mutations there are and the better treatments to counter them. Hard to predict precise timing of rerate, so fortune favours the patient

it’s AIM investment, not an exact science. Fact remains Orph has a highly relevant and unique Immunology platform at a time when every single news bulletin in the world is full of discussion of variants and vaccines. In a sector worth hundreds of billions, you have to work out for yourself whether or not that IP and expertise is worth something more than the current MCAP. The rest remains noise.

there is also of course a well-known dopamine hit for certain narcissistic personality types in being the eternal contrarian or troll... whatever floats your boat I guess

https://www.vice.com/en/article/a33yq8/trolling-addiction

it's PepTcell, Jim, but not as we know it

the unique CHIM data for flu and colds goes back to 1947, which I guess is quite tricky for newbies to replicate

Jesus the guy can’t win, first too chirpy now not chirpy enough!

As you know, I'm referring to your Bronxville history at Fastnet

so you think it will help you to get back above water here by continuing to attempt to poison the reputation of the CEO on an hourly basis - which you also did with Fastnet/Amryt?

It's not mandatory to invest here, JB, why not pick a share where the CEO is entirely circumspect if that's your bag?

So it's fine for you to simply make stuff up whenever you want to JB - but if CF slightly over-promises about timelines in his enthusiasm for an extraordinary business that he is putting his soul and cash, into you believe it warrants weird stalker-ish character assassination on a daily basis over a period of years?

First rule of AIM seems appropriate for Wayz: no one who holds shares talks shares down unless they want to buy some more

Barwickman, nothing scaremongering about this:
https://www.nature.com/articles/s41598-021-83040-3

Not sure it’s within the gift of IOG to tell DT columnists what to write about. It’s not a story until it’s a story